Stock Price Targets and Analyst Ratings

Stay on top of the latest U.S. and international stock analyst recommendations with our up-to-date list of stock price targets and analyst ratings. This page tracks newly issued analyst ratings, price targets, upgrades, downgrades, and other broker actions to help you see how Wall Street analysts view the companies you follow. Use these ratings to compare sentiment, spot shifts in outlook, and make more informed investment decisions.

Company	Action	Brokerage	Analyst	Current Price	Price Target	Rating
AAL Anglo American	Reiterated by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 3,768 -2.8%	GBX 5,000 ➝ GBX 5,000	Buy
AAPL Apple	Target Raised by	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Krish Sankar Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$290.55 -3.6%	$335.00 ➝ $350.00	Buy
AAPL Apple	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Erik Woodring Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$290.55 -3.6%	$330.00 ➝ $360.00	Overweight
AAPL Apple	Reiterated by	Needham & Company LLC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Laura Martin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$290.55 -3.6%		Hold
AAPL Apple	Reiterated by	Rosenblatt Securities Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Barton Crockett Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$290.55 -3.6%	$276.00	Neutral
AAPL Apple	Reiterated by	KeyCorp Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$290.55 -3.6%		Sector Weight
AAPL Apple	Reiterated by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Tim Long Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$290.55 -3.6%		Underweight
AAPL Apple	Reiterated by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	David Vogt Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$290.55 -3.6%		Buy
AAPL Apple	Reiterated by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$290.55 -3.6%		Hold
AAPL Apple	Target Set by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Erik Woodring Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$290.55 -3.6%	$325.00
RE: Your MarketBeat Account Status (Ad) Your $100 MarketBeat account credit expires in less than twelve hours. Upgrade to MarketBeat All Access today and save $100 on your 2026 MarketBeat premium subscription. Claim My Discount
AAPL Apple	Reiterated by	Oppenheimer Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$290.55 -3.6%		Market Perform
AAPL Apple	Reiterated by	Maxim Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Tom Forte Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$290.55 -3.6%	$310.00 ➝ $350.00	Buy
ABDN abrdn	Target Raised by	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 232.20 -2.0%	GBX 235 ➝ GBX 265	Buy
AHEXY Adecco	Downgraded by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$10.10 -1.9%		Cautious ➝ Underweight
AJB AJ Bell	Target Raised by	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 613.16 +2.0%	GBX 600 ➝ GBX 675	Buy
AKR Acadia Realty Trust	Target Raised by	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ki Bin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$22.55 +1.6%	$23.00 ➝ $24.00	Buy
ALKS Alkermes	Target Raised by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Leonid Timashev Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$44.29 +4.3%	$45.00 ➝ $56.00	Outperform
AMZN Amazon.com	Reiterated by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ross Sandler Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$244.19 -0.4%		Overweight
ANTO Antofagasta	Reiterated by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 3,846 -3.8%	GBX 4,500 ➝ GBX 4,500	Hold
APLD Applied Digital	Reiterated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$41.91 +2.4%		Market Outperform
APLD Applied Digital	Target Raised by	Needham & Company LLC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	John Todaro Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$41.91 +2.4%	$66.00 ➝ $83.00	Buy
APLD Applied Digital	Target Raised by	Craig Hallum Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	George Sutton Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$41.91 +2.4%	$75.00 ➝ $79.00	Buy
APLD Applied Digital	Target Raised by	Lake Street Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Rob Brown Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$41.91 +2.4%	$70.00 ➝ $90.00	Buy
APN APN Resources	Target Raised by	Berenberg Bank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 288.73 +2.2%	GBX 290 ➝ GBX 340	Buy
APP AppLovin	Reiterated by	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	James Callahan Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$520.84 -7.6%		Overweight
ARCB ArcBest	Target Raised by	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jason H. Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$173.22 +4.2%	$137.00 ➝ $175.00	Hold
ASND Ascendis Pharma A/S	Reiterated by	Oppenheimer Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$213.23 +3.6%		Outperform
AU AngloGold Ashanti	Target Raised by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ephrem Ravi Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$84.34 -0.2%	$120.00 ➝ $130.00	Buy
AZN Astrazeneca	Reiterated by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$183.36 +1.0%		Buy
AZN Astrazeneca	Reiterated by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$183.36 +1.0%		Buy
AZN Astrazeneca	Reiterated by	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$183.36 +1.0%		Sell
AZN AstraZeneca	Reiterated by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		£136.74 -1.0%	£180 ➝ £180	Buy
BATS British American Tobacco	Reiterated by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 4,466.11 -0.7%	GBX 5,200 ➝ GBX 5,200	Buy
BBCP Concrete Pumping	Target Raised by	Robert W. Baird Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Andrew Wittmann Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$10.71 -0.8%	$8.00 ➝ $12.00	Neutral
BBUC Brookfield Business	Initiated by	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Bill Katz Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$32.37 +1.9%	$34.00	Hold
BHP BHP Group	Reiterated by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 3,115 -1.5%	GBX 3,600 ➝ GBX 3,600	Hold
BLBD Blue Bird	Target Set by	DA Davidson Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael Shlisky Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$71.16 +1.3%	$86.00
BLND British Land	Target Lowered by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 403.60 +1.5%	GBX 440 ➝ GBX 430	Neutral
BRAG Bragg Gaming Group	Target Set by	Maxim Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jack Vander Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$1.69 -0.6%	$6.00
BRC Brady	Upgraded by	Sidoti Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Steve Ferazani Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$76.11 +1.1%	$103.00	Neutral ➝ Buy
Goldman Sachs just told you what to buy (most people missed it) (Ad) Goldman Sachs just revealed that 40% of AI data centers will be crippled by electricity shortages by 2027 - not chips, not funding, but power. Demand is growing 15% per year and the grid can't keep up. One small company makes the exact equipment these data centers need. They're sitting on $1.5 billion in orders, their hardware is already inside Musk's Colossus, and the stock still trades like a name nobody's heard of. Analyst Dylan Jovine is releasing the ticker for free. See the stock positioned to solve AI's biggest power crisis
BRO Brown & Brown	Target Lowered by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Weston Bloomer Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$59.05 +1.8%	$81.00 ➝ $65.00	Neutral
BWIN Baldwin Insurance Group	Target Lowered by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brian Meredith Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$19.36 +0.6%	$40.00 ➝ $35.00	Buy
BX Blackstone	Target Lowered by	Rothschild & Co Redburn Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$120.03 +5.1%	$134.00 ➝ $130.00	Neutral
BYG Big Yellow Group	Target Lowered by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 838 +1.8%	GBX 1,250 ➝ GBX 1,190	Overweight
BZLFY Bunzl	Upgraded by	BNP Paribas Exane Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$17.19 +2.6%		Neutral ➝ Outperform
CAR Avis Budget Group	Target Raised by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ryan Brinkman Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$181.34 +1.3%	$140.00 ➝ $155.00	Underweight
CDNS Cadence Design Systems	Target Raised by	Stifel Nicolaus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ruben Roy Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$390.90 -0.8%	$395.00 ➝ $432.00	Buy
CFG Citizens Financial Group	Reiterated by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$65.61 +2.0%		Overweight
CLF Cleveland-Cliffs	Upgraded by	Glj Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Gordon L. Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$12.75 +0.6%	$9.03 ➝ $15.01	Sell ➝ Hold
CLPT ClearPoint Neuro	Target Set by	Stifel Nicolaus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Tom Stephan Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$13.59 +1.6%	$16.00
CNI Canadian National Railway	Target Raised by	Canadian Imperial Bank of Commerce Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Kevin Chiang Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$120.40 -0.3%	C$164.00 ➝ C$182.00	Outperformer
CNK Cinemark	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Benjamin Swinburne Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$31.97 +1.6%	$30.00 ➝ $36.00	Equal Weight
COST Costain Group	Reiterated by	Berenberg Bank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 190 +1.6%	GBX 240 ➝ GBX 240	Buy
CP Canadian Pacific Kansas City	Target Set by	Canadian Imperial Bank of Commerce Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Kevin Chiang Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$90.29 +0.3%	$140.00
CPB Campbell's	Target Lowered by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Peter Grom Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$22.13 +3.0%	$19.00 ➝ $17.00	Sell
CPB Campbell's	Target Lowered by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Nik Modi Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$22.13 +3.0%	$23.00 ➝ $21.00	Sector Perform
CPB Campbell's	Target Set by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Peter Grom Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$22.13 +3.0%	$17.00
CPB Campbell's	Reiterated by	Sanford C. Bernstein Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Alexia Howard Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$22.13 +3.0%	$21.00 ➝ $19.00	Market Perform ➝ Underperform
CPB Campbell's	Target Lowered by	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Peter Galbo Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$22.13 +3.0%	$20.00 ➝ $18.00	Underperform
CROX Crocs	Target Set by	Williams Trading Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Sam Poser Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$127.77 +5.9%	$150.00
CTVA Corteva	Target Lowered by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Joshua Spector Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$74.95 -1.2%	$90.00 ➝ $86.00	Neutral
DHC Diversified Healthcare Trust	Target Raised by	B. Riley Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	John Massocca Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$8.79 +5.9%	$8.50 ➝ $11.00	Buy
DTIL Precision BioSciences	Initiated by	Oppenheimer Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Joseph Thome Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$6.86 +1.3%	$20.00	Outperform
DUOL Duolingo	Target Raised by	DA Davidson Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Wyatt Swanson Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$117.86 -0.1%	$90.00 ➝ $120.00	Neutral
DXCM DexCom	Target Set by	Mizuho Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Anthony Petrone Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$78.19 +2.0%	$75.00 ➝ $85.00	Outperform
ELVN Enliven Therapeutics	Initiated by	Stifel Nicolaus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Dara Azar Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$36.11 +7.4%	$60.00	Buy
ENSG The Ensign Group	Reiterated by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$155.25 -0.7%		Outperform
EPR EPR Properties	Target Lowered by	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael Lewis Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$59.00 +2.4%	$62.00 ➝ $61.00	Hold
ETOR eToro Group	Reiterated by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Joseph Vafi Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$38.17 -2.4%	$65.00	Buy
EVLV Evolv Technologies	Reiterated by	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Shaul Eyal Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$6.05 +4.0%	$10.00	Buy
EXPE Expedia Group	Reiterated by	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jake Fuller Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$231.06 +2.3%	$330.00	Buy
FCEL FuelCell Energy	Reiterated by	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jeff Osborne Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$17.49 +12.8%	$9.00 ➝ $16.00	Hold
FCEL FuelCell Energy	Target Set by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	George Gianarikas Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$17.49 +12.8%	$12.00 ➝ $30.00	Hold ➝ Buy
FCEL FuelCell Energy	Target Raised by	B. Riley Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Christopher Souther Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$17.49 +12.8%	$8.00 ➝ $13.00	Neutral
FCEL FuelCell Energy	Reiterated by	KeyCorp Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$17.49 +12.8%		Sector Weight
FEVR Fevertree Drinks	Reiterated by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 801 +5.5%	GBX 1,080 ➝ GBX 1,080	Buy
FFIV F5	Target Raised by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Matthew Hedberg Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$395.23 -0.2%	$425.00 ➝ $450.00	Outperform
FICO Fair Isaac	Reiterated by	Needham & Company LLC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Kyle Peterson Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$1,224.37 +1.4%	$1,650.00	Buy
FVR FrontView REIT	Initiated by	Raymond James Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	RJ Milligan Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$19.42 +2.3%	$22.00	Strong-Buy
GHM Graham	Target Raised by	Oppenheimer Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Christopher Glynn Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$99.91 +4.8%	$100.00 ➝ $110.00	Outperform
GHM Graham	Target Set by	Northland Securities Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$99.91 +4.8%	$111.00
GILD Gilead Sciences	Reiterated by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$125.50 -2.0%		Overweight
GLEN Glencore	Reiterated by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 574.09 -2.5%	GBX 720 ➝ GBX 720	Buy
GLOO Gloo	Target Raised by	Benchmark Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Daniel Kurnos Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$4.78 -5.9%	$14.00 ➝ $15.00	Buy
GMED Globus Medical	Reiterated by	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$82.60 +5.5%		Overweight
GOLD Gold.com	Initiated by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brian McNamara Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$41.98 +3.7%	$70.00	Buy
GOLD Gold.com	Initiated by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$41.98 +3.7%	$70.00	Buy
GOOG Alphabet	Target Raised by	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	John Blackledge Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$362.29 +0.3%	$450.00 ➝ $475.00	Buy
GPN Global Payments	Target Lowered by	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$63.86 -1.0%	$75.00 ➝ $70.00	Hold
GRPN Groupon	Reiterated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$16.61 +2.7%		Outperform
RE: Your MarketBeat Account Status (Ad) Your $100 MarketBeat account credit expires in less than twelve hours. Upgrade to MarketBeat All Access today and save $100 on your 2026 MarketBeat premium subscription. Claim My Discount
GSHD Goosehead Insurance	Target Lowered by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brian Meredith Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$35.92 -1.6%	$85.00 ➝ $67.00	Buy
GSK GSK	Reiterated by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$51.16 +1.0%		Outperform
GVDNY Givaudan	Upgraded by	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$79.22 +8.0%		Hold ➝ Buy
GYM The Gym Group	Reiterated by	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 208 +1.2%	GBX 230 ➝ GBX 230	Buy
HAS Hasbro	Target Lowered by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Anthony Bonadio Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$84.26 +0.9%	$92.00 ➝ $85.00	Equal Weight
HFD Halfords Group	Reiterated by	Shore Capital Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 183 +2.2%		Buy
HOOD Robinhood Markets	Reiterated by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ramsey El-Assal Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$83.77 -1.5%	$110.00	Overweight
HURN Huron Consulting Group	Target Lowered by	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Tobey Sommer Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$110.54 +0.8%	$155.00	Buy
IFF International Flavors & Fragrances	Initiated by	Benchmark Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$75.79 +4.4%	$100.00	Buy
INCY Incyte	Target Raised by	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Mitchell S. Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$103.23 +2.6%	$135.00 ➝ $140.00	Buy
INCY Incyte	Target Set by	Stifel Nicolaus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Stephen Willey Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$103.23 +2.6%	$123.00
INCY Incyte	Reiterated by	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$103.23 +2.6%		Hold
INGR Ingredion	Reiterated by	Benchmark Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ben Klieve Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$101.49 +1.8%		Buy
IVVD Invivyd	Reiterated by	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Thomas Shrader Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$0.99 -2.9%	$10.00	Buy
JAZZ Jazz Pharmaceuticals	Target Set by	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Gregory Renza Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$229.19 -1.2%	$256.00	Buy
JAZZ Jazz Pharmaceuticals	Reiterated by	Sanford C. Bernstein Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jeffrey Walch Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$229.19 -1.2%		Market Perform
JBL Jabil	Target Raised by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	David Vogt Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$361.89 -0.6%	$273.00 ➝ $380.00	Neutral
JCI Johnson Controls International	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Christopher Snyder Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$147.62 +2.5%	$140.00 ➝ $175.00	Overweight
JEF Jefferies Financial Group	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ryan Kenny Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$58.96 +1.8%	$44.00 ➝ $50.00	Equal Weight
KEY Keyera	Target Set by	TD Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$57.38 +0.1%	C$68.00	Buy
KFY Korn/Ferry International	Target Raised by	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Tobey Sommer Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$73.69 +1.4%	$75.00 ➝ $80.00	Buy
KLAC KLA	Reiterated by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Timothy Arcuri Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$2,139.37 +1.5%	$1,770.00 ➝ $2,180.00	Neutral
KPTI Karyopharm Therapeutics	Reiterated by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$8.69 +2.2%		Overweight
KSI kneat.com	Downgraded by	TD Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$6.43	C$6.00 ➝ C$6.50	Buy ➝ Sell
KYNB Kyntra Bio	Initiated by	Rodman & Renshaw Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael G. Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$6.69 +0.9%	$30.00	Buy
LAZ Lazard	Reiterated by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael Brown Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$47.18 +3.1%	$44.00	Neutral
LBG LBG Media	Target Lowered by	Berenberg Bank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 25.32 -27.0%	GBX 90 ➝ GBX 45	Buy
LEN Lennar	Downgraded by	Keefe, Bruyette & Woods Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jade Rahmani Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$92.63 +2.1%	$97.00 ➝ $86.00	Market Perform ➝ Underperform
LGEN Legal & General Group	Target Raised by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 269.90 -0.3%	GBX 2,490 ➝ GBX 2,510	Neutral
LITE Lumentum	Reiterated by	Needham & Company LLC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ryan Koontz Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$821.76 -8.2%	$1,040.00	Buy
LKNCY Luckin Coffee	Initiated by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$31.20 +1.9%	$43.60	Buy
LLY Eli Lilly and Company	Target Raised by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Akash Tewari Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$1,143.29 -0.5%	$1,330.00 ➝ $1,350.00	Buy
LOPE Grand Canyon Education	Initiated by	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jasper Bibb Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$149.65 +0.7%	$200.00	Buy
LOPE Grand Canyon Education	Target Set by	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jasper Bibb Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$149.65 +0.7%	$100.00
LRCX Lam Research	Reiterated by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Timothy Arcuri Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$327.16 +0.8%	$310.00 ➝ $375.00	Buy
LULU lululemon athletica	Target Lowered by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Paul Lejuez Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$121.36 +3.2%	$185.00 ➝ $130.00	Neutral
LULU lululemon athletica	Target Lowered by	Daiwa Securities Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$121.36 +3.2%	$173.00 ➝ $120.00	Neutral
LXP LXP Industrial Trust	Reiterated by	KeyCorp Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$52.58 +2.0%		Sector Weight
LYEL Lyell Immunopharma	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Mitchell S. Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$12.70 +3.2%	$45.00	Buy
LYEL Lyell Immunopharma	Reiterated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$12.70 +3.2%		Market Outperform
LYTS LSI Industries	Initiated by	Oppenheimer Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brent Thielman Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$24.53 +4.6%	$30.00	Outperform
MGNI Magnite	Initiated by	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Tyler DiMatteo Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$15.81 +8.1%	$20.00	Buy
MLTX MoonLake Immunotherapeutics	Reiterated by	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Julian Harrison Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$17.80 -1.1%	$30.00	Buy
MNG M&G	Target Raised by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 313.70 -0.2%	GBX 2,880 ➝ GBX 2,950	Neutral
MPAA Motorcar Parts of America	Reiterated by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$13.20 -7.4%		Overweight
MRSH Marsh & McLennan Companies	Target Lowered by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brian Meredith Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$165.52 +1.8%	$230.00 ➝ $203.00	Buy
MTN Vail Resorts	Target Lowered by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brandt Montour Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$131.27 -4.3%	$138.00 ➝ $119.00	Underweight
MTN Vail Resorts	Target Lowered by	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$131.27 -4.3%	$143.00 ➝ $134.00	Hold
MTN Vail Resorts	Target Lowered by	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Patrick Scholes Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$131.27 -4.3%	$212.00 ➝ $195.00	Buy
MTN Vail Resorts	Target Raised by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Matthew Boss Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$131.27 -4.3%	$124.00 ➝ $126.00	Neutral
Tomorrow's Stock of the Day (Ad) Looking for better stock ideas? Sign-up to receive The Early Bird Stock of the Day. Each day, MarketBeat's team of expert research analysts identifies one compelling stock and provides both a bull case and a bear case for each company. Get The Early Bird's Stock of the Day (Free)
MTN Vail Resorts	Reiterated by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Arpine Kocharyan Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$131.27 -4.3%		Neutral
MTN Vail Resorts	Target Lowered by	Stifel Nicolaus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jeffrey Stantial Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$131.27 -4.3%	$172.00 ➝ $167.00	Buy
MTN Vail Resorts	Target Set by	Mizuho Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ben Chaiken Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$131.27 -4.3%	$174.00
MVCT Molten Ventures VCT	Target Raised by	Berenberg Bank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 38.80	GBX 645 ➝ GBX 790	Buy
NB NioCorp Developments	Initiated by	B. Riley Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$4.99	$12.00	Buy
NGNE Neurogene	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Mitchell S. Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$28.81 +0.7%	$70.00	Buy
NOVT Novanta	Target Set by	Robert W. Baird Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Quinn Fredrickson Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$160.65 -2.2%	$180.00
NRIX Nurix Therapeutics	Target Raised by	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jeet Mukherjee Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$15.64	$30.00 ➝ $32.00	Buy
NUVL Nuvalent	Downgraded by	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Swayampakula Ramakanth Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$123.25 +39.3%	$124.00	Buy ➝ Neutral
NUVL Nuvalent	Downgraded by	Wedbush Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	David Nierengarten Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$123.25 +39.3%	$125.00 ➝ $124.00	Outperform ➝ Neutral
NUVL Nuvalent	Reiterated by	Lifesci Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$123.25 +39.3%	$124.00	Outperform ➝ Market Perform
NUVL Nuvalent	Downgraded by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Josh Schimmer Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$123.25 +39.3%		Overweight ➝ Neutral
NUVL Nuvalent	Downgraded by	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$123.25 +39.3%	$124.00	Overweight ➝ Neutral
NUVL Nuvalent	Downgraded by	Raymond James Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$123.25 +39.3%		Outperform ➝ Market Perform
NUVL Nuvalent	Target Set by	Stifel Nicolaus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$123.25 +39.3%	$124.00
NUVL Nuvalent	Target Set by	Robert W. Baird Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$123.25 +39.3%	$122.85
NUVL Nuvalent	Reiterated by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Eva Fortea Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$123.25 +39.3%	$116.00 ➝ $124.00	Overweight ➝ Equal Weight
NUVL Nuvalent	Target Set by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$123.25 +39.3%	$124.00
NXPI NXP Semiconductors	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Joe Quatrochi Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$297.41 -1.2%	$265.00 ➝ $305.00	Equal Weight
ODFL Old Dominion Freight Line	Target Raised by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Stephanie Moore Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$248.73 +0.7%	$230.00 ➝ $250.00	Hold
OGS ONE Gas	Target Lowered by	Mizuho Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Gabriel Moreen Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$76.07 -0.1%	$94.00 ➝ $89.00	Outperform
OHI Omega Healthcare Investors	Target Lowered by	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael Lewis Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$45.62 +4.2%	$48.00 ➝ $46.00	Hold
OKTA Okta	Target Raised by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Roger Boyd Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$119.96 +2.7%	$115.00 ➝ $150.00	Buy
OLP One Liberty Properties	Target Raised by	B. Riley Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	John Massocca Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$24.49 +1.3%	$27.50 ➝ $28.50	Buy
ON onsemi	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Joe Quatrochi Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$117.00 -3.2%	$115.00 ➝ $140.00	Overweight
ORCL Oracle	Target Raised by	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brad Sills Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$205.45 -3.0%	$200.00 ➝ $240.00	Buy
OTB On the Beach Group	Upgraded by	Shore Capital Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 155 +2.6%	GBX 210 ➝ GBX 210	Buy
OVV Ovintiv	Target Set by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$56.52 -2.4%	$70.00	Outperform
PAR PAR Technology	Upgraded by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ella Smith Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$13.58 +2.3%	$12.00 ➝ $16.00	Underweight ➝ Neutral
PAR PAR Technology	Target Set by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$13.58 +2.3%	$16.00
PAR PAR Technology	Target Set by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$13.58 +2.3%	$16.00
PEGA Pegasystems	Reiterated by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Rishi Jaluria Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$34.16 -2.7%		Outperform
PKE Park Aerospace	Initiated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$34.51 +8.2%		Outperform
PKE Park Aerospace	Initiated by	Citizens Jmp Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Trevor Walsh Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$34.51 +8.2%	$42.00	Market Outperform
PLTK Playtika	Reiterated by	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$3.08 +1.0%		Buy
PRIM Primoris Services	Reiterated by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Manish A. Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$103.95 -15.4%		Neutral
PRM Perimeter Solutions	Initiated by	CJS Securities Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Will Gildea Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$32.70 +5.2%	$48.00	Market Outperform
PRU Prudential Financial	Downgraded by	Argus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jacob Kilstein Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$103.58 -0.1%		Buy ➝ Hold
PSTL Postal Realty Trust	Target Set by	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael Lewis Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$23.45 +2.9%	$25.00
PTCT PTC Therapeutics	Upgraded by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Geoff Meacham Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$73.68 +4.0%	$75.00 ➝ $108.00	Neutral ➝ Buy
RAL Ralliant	Initiated by	Evercore Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$63.66 +4.3%	$80.00	Outperform
RH RH	Target Lowered by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael Lasser Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$150.48 +2.5%	$160.00 ➝ $155.00	Neutral
RIO Rio Tinto Group	Reiterated by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 7,469 -1.3%	GBX 8,500 ➝ GBX 8,500	Hold
RNAC Cartesian Therapeutics	Reiterated by	Needham & Company LLC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Gil Blum Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$6.85 +16.9%	$40.00	Buy
RNAC Cartesian Therapeutics	Reiterated by	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Julian Harrison Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$6.85 +16.9%	$44.00	Buy
ROKU Roku	Target Raised by	Guggenheim Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael Morris Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$120.91 -2.2%	$140.00 ➝ $145.00	Buy
RYAN Ryan Specialty	Target Raised by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brian Meredith Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$33.41 +5.6%	$51.00 ➝ $52.00	Buy
S32 South32	Reiterated by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 237.80 -2.4%	GBX 300 ➝ GBX 300	Buy
SAIL SailPoint	Reiterated by	Scotiabank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Patrick Colville Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$15.66 -11.5%	$19.00	Outperform
SAIL SailPoint	Reiterated by	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Gray Powell Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$15.66 -11.5%	$18.00	Buy
Goldman Sachs just told you what to buy (most people missed it) (Ad) Goldman Sachs just revealed that 40% of AI data centers will be crippled by electricity shortages by 2027 - not chips, not funding, but power. Demand is growing 15% per year and the grid can't keep up. One small company makes the exact equipment these data centers need. They're sitting on $1.5 billion in orders, their hardware is already inside Musk's Colossus, and the stock still trades like a name nobody's heard of. Analyst Dylan Jovine is releasing the ticker for free. See the stock positioned to solve AI's biggest power crisis
SBRY J Sainsbury	Target Lowered by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 303.90 +0.7%	GBX 3,350 ➝ GBX 3,300	Neutral
SCGLY Societe Generale Group	Reiterated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$16.28 +2.1%		Buy
SNX TD SYNNEX	Target Raised by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	David Vogt Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$272.41 +0.2%	$265.00 ➝ $310.00	Buy
SPG Simon Property Group	Target Set by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$211.79 +2.1%	$207.00
SPRB Spruce Biosciences	Initiated by	JonesTrading Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Catherine Novack Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$49.03 -0.6%	$135.00	Buy
SPTX Seaport Therapeutics	Downgraded by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$17.66 +9.0%		Sell
SRAD Sportradar Group	Reiterated by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Robin Farley Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$16.40 +7.5%		Buy
STLA Stellantis	Reiterated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$7.05 -0.5%		Neutral
SWX Southwest Gas	Target Raised by	Mizuho Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Gabriel Moreen Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$88.19 -0.2%	$96.00 ➝ $98.00	Outperform
SYNA Synaptics	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Joe Quatrochi Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$130.88 -3.8%	$120.00 ➝ $155.00	Overweight
TAC TransAlta	Target Set by	BMO Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ben Pham Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$12.46 -0.4%	$25.00
TATYY Tate & Lyle	Downgraded by	BNP Paribas Exane Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$30.15 +1.0%		Neutral
TEO Telecom Argentina Stet - France Telecom	Target Raised by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Marcelo Santos Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$14.11 +5.5%	$16.00 ➝ $19.00	Overweight
TFII TFI International	Reiterated by	BMO Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$159.38 -2.4%	$140.00 ➝ $170.00	Market Perform
TJX TJX Companies	Reiterated by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jay Sole Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$164.57 +3.0%		Buy
TNGX Tango Therapeutics	Target Raised by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	John Newman Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$31.56 +2.0%	$30.00 ➝ $42.00	Buy
TNGX Tango Therapeutics	Target Raised by	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Robert Burns Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$31.56 +2.0%	$27.00 ➝ $66.00	Buy
TOL Toll Brothers	Upgraded by	Keefe, Bruyette & Woods Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jade Rahmani Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$144.29 +5.2%	$158.00 ➝ $161.00	Market Perform ➝ Outperform
TOL Toll Brothers	Upgraded by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	John Lovallo Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$144.29 +5.2%		Buy
TOL Toll Brothers	Downgraded by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Mike Dahl Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$144.29 +5.2%		Outperform ➝ Sector Perform
TOL Toll Brothers	Initiated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$144.29 +5.2%		Neutral ➝ Outperform
TOL Toll Brothers	Downgraded by	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$144.29 +5.2%		Overweight ➝ Neutral
TOL Toll Brothers	Downgraded by	Oppenheimer Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$144.29 +5.2%		Outperform ➝ Market Perform
TOL Toll Brothers	Initiated by	Benchmark Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$144.29 +5.2%		Buy
TOL Toll Brothers	Initiated by	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$144.29 +5.2%		Neutral ➝ Buy
TRTX TPG RE Finance Trust	Reiterated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$8.56 +2.7%		Market Outperform
TSCO Tesco	Reiterated by	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 455.90 +0.4%	GBX 525 ➝ GBX 525	Buy
TTWO Take-Two Interactive Software	Reiterated by	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	James Callahan Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$212.05 -0.2%		Neutral
TVK TerraVest Industries	Target Lowered by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$115.22 +6.0%	C$190.00 ➝ C$140.00	Buy
TWFG TWFG	Target Lowered by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brian Meredith Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$20.65 +3.8%	$31.00 ➝ $26.00	Buy
TWO Two Harbors Investments	Reiterated by	Compass Point Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Merrill Ross Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$12.40 +0.3%	$13.00	Neutral
TXN Texas Instruments	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Joe Quatrochi Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$288.63 -0.8%	$260.00 ➝ $300.00	Equal Weight
UBER Uber Technologies	Reiterated by	Guggenheim Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Taylor Manley Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$70.43 +0.5%		Buy
UCTT Ultra Clean	Target Raised by	Oppenheimer Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Edward Yang Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$91.88 +9.5%	$100.00 ➝ $115.00	Outperform
ULTA Ulta Beauty	Target Lowered by	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Oliver Chen Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$477.90 +3.3%	$700.00 ➝ $600.00	Buy
VCT Victrex	Target Lowered by	Berenberg Bank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 600 +0.3%	GBX 695 ➝ GBX 600	Hold
VEON VEON	Initiated by	Northland Securities Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Tim Savageaux Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$49.27 +0.5%	$70.00	Outperform
VFS VinFast Auto	Reiterated by	Chardan Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	James McIlree Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$3.04 -0.3%	$5.50	Buy
VFS VinFast Auto	Target Lowered by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Andres Sheppard Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$3.04 -0.3%	$6.00 ➝ $5.00	Overweight
WING Wingstop	Target Lowered by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Dennis Geiger Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$143.86 +0.3%	$210.00 ➝ $160.00	Neutral
WIX Wix.com	Target Lowered by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jamesmichael Sherman-Lewis Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$48.22 +0.0%	$66.00 ➝ $59.00	Neutral
WIX Wix.com	Target Lowered by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brad Erickson Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$48.22 +0.0%	$60.00 ➝ $45.00	Sector Perform
WIX Wix.com	Target Lowered by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Alec Brondolo Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$48.22 +0.0%	$54.00 ➝ $47.00	Equal Weight
WIX Wix.com	Reiterated by	Benchmark Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Mark Zgutowicz Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$48.22 +0.0%		Buy
WIX Wix.com	Reiterated by	Scotiabank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Nat Schindler Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$48.22 +0.0%		Outperform
WKP Workspace Group	Target Lowered by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 331.75 +0.3%	GBX 500 ➝ GBX 410	Overweight
WPP WPP	Reiterated by	Berenberg Bank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 277 +5.6%	GBX 405 ➝ GBX 405	Buy
WPP WPP	Initiated by	Berenberg Bank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$18.68 +7.0%		Buy
WST West Pharmaceutical Services	Upgraded by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Luke Sergott Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$334.84 +4.7%	$310.00 ➝ $400.00	Equal Weight ➝ Overweight
WTW Willis Towers Watson Public	Target Lowered by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brian Meredith Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$261.16 +1.2%	$400.00 ➝ $374.00	Buy
WYFI WhiteFiber	Initiated by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Raimo Lenschow Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$23.29 -0.5%	$27.00	Equal Weight
ZVRA Zevra Therapeutics	Target Raised by	Citizens Jmp Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jason Butler Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$13.66 +13.0%	$18.00 ➝ $25.00	Market Outperform
ZVRA Zevra Therapeutics	Reiterated by	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Kambiz Yazdi Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$13.66 +13.0%	$23.00 ➝ $27.00	Buy
ZVRA Zevra Therapeutics	Reiterated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$13.66 +13.0%		Outperform
ZVRA Zevra Therapeutics	Target Raised by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Sumant Kulkarni Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$13.66 +13.0%	$24.00 ➝ $29.00	Buy
ZVRA Zevra Therapeutics	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$13.66 +13.0%		Buy
ZYME Zymeworks	Target Set by	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Gregory Renza Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$23.26 -2.8%	$28.00	Buy

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Tuesday at 04:21 PM ET.

Stock Ratings and Recommendations: Understanding Analyst Ratings

Written by MarketBeat Staff

Key Points

Stock analysts give ratings to companies based on their research and insights.
Analysis comes from the buy side (fund companies, investment managers) or sell side (brokers, banks).
Analysts use different methodologies, so investors should always look into why a particular rating was given.
5 stocks we like better than EXA)

You'll often hear a particular stock called a "buy" or "sell," but who exactly makes these calls? Ratings and recommendations come from stock analysts, who research different securities and work for various institutions, brokerage firms and other financial companies.

Analyst ratings are designed to give additional information to investors beyond just what the company is saying, but are analyst ratings reliable? In this article, we'll discuss how to read analyst ratings, what goes into their decision-making process and how potential conflicts of interest influence analyst stock ratings.

What Are Analyst Ratings?

A stock rating is a simple heuristic given by analysts who review the firm's financial statements, listen to conference calls, chat with company executives and compare the stock to others in the industry or sector. Finally, an analyst uses all this information to produce a simple recommendation and price target.

When a public analyst goes on CNBC or the "Wall Street Journal" to give a "buy" or "sell" rating on a particular stock, they take all their research and pare it down into a simple designation. While there's no true consensus on what constitutes a buy or sell rating, an analyst usually does have "skin in the game" when devising ratings.

Ratings often pair with price targets, which put a hard number on what the analysts believe the company stock should be worth. So, for example, you might see an analyst report something like, "Buy NVIDIA Inc. (NASDAQ: NVDA), price target $350," which means that particular analyst believes investors should buy NVDA shares up to a price of $350 per share.

Analyst ratings infographic: What you need to know

What Does a Stock Analyst Do?

A stock analyst is a market professional with the skills to interpret financial data and the connections within companies to speak on the record with higher-ups. Analysts generally fall into one of two different camps: buy-side or sell-side. These positions will seem similar, but they tend to be employed by various institutions and have different responsibilities in their particular market "territories."

Buy-side analysts: Analysts on the buy side tend to work for funds, such as ETF providers or hedge funds. They don't dig as deeply into company financial data or conference calls as sell-siders. Instead, they focus on general areas or industries where their funds have vested interests. In addition, buy-side analysts often forge relationships with sell-side analysts for individual stock research. A buy-side analyst's primary goal is to find and utilize the most accurate and dependable sell-side analysts.
Sell-side analysts: If buy-side analysts work for funds (i.e., institutions that buy securities), you can probably guess which type of institution employs sell-side analysts. Brokers, banks and other firms that sell securities to investors use sell-side analysts to give reports to the public. While buy-side analysts also give ratings and price targets, the reported "buy" and "sell" ratings in financial media typically come from folks on the sell side.

Buy and sell-side analysts often use different rating systems when making their recommendations. You might even find two sell-side analysts with similar "buy" recommendations with vastly different price targets in the same stock. As a result, you'll need to familiarize yourself with the various methodologies analysts use to utilize their research correctly.

What Ratings Do Analysts Give?

Stock analyst ratings don't follow a strict structure, although most have roughly the same grading system for the securities they review. The labels may differ slightly (i.e., overweight vs. outperform), but the five most common analyst ratings go like this.

Buy

Analysts bullish on a particular security will give it a "buy" rating and set a price target above the current market price. In addition, if the analyst considers the stock one of the best in the industry or sector, you'll sometimes see a "strong buy" rating attached.

Hold

A "hold" rating is typically the lowest rating a sell-side analyst gives a stock. "Hold" means the analyst projects the stock to meet the return of the market averages, making it an unspectacular investment. Stocks rated "hold" may still have a price target above the current price, but it's not likely to surpass the return of a major index like the S&P 500.

Sell

Analysts are usually apprehensive about giving a stock a "sell" rating. For example, suppose a "hold" rating indicates indecision over the stock's future. In this scenario, a "sell" rating is issued when an analyst finds something unappealing, such as questionable accounting tactics or cratering sales growth.

Underperform

Analysts won't always give a firm "buy" or "sell" rating on stock but will instead label it "underperform" or "outperform." "Underperform" means the analyst expects the stock not to keep up with the market. It doesn't necessarily mean the analyst predicts a crash but indicates a lack of confidence in the shares.

Outperform

"Outperform" is the opposite of "underperform," meaning the analyst expects the stock to do better than the market average. It's usually considered a less confident rating than "buy."

Example of an Analyst Rating

You can use MarketBeat Analyst Ratings to find ranges and aggregates from buy- and sell-side analysts across the financial media. For example, here's a stock that analysts usually love: Alphabet Inc. (NASDAQ: GOOG).

Overview of stock analysis on GOOG Using MarketBeat's tools, you can find ratings from prominent analysts from multiple periods. Alphabet is currently labeled a "moderate buy" based on MarketBeat's consensus from 17 analysts. You'll get the consensus price target and the highest and lowest from the analysts surveyed.

Marketbeat's tools detailing analyst ratings

Looking at analyst recommendations over time is another helpful tool. For example, you can view the different levels of coverage over the last few years, which analysts changed their ratings and how the price targets vary from month to month. If an analyst can't get a good read on a particular stock they've been covering, they might choose to withhold their grade, which is one reason why the number of available ratings can change over time.

Overview of analyst ratings on MarketBeat Analysts from both sides of the aisle can be found on MarketBeat, ranging from large firms like JPMorgan Chase and Co. (NYSE: JPM) to smaller investment banks like Roth Capital. Some institutions like UBS Group offer both buy-side and sell-side ratings and analysis. These graphs show that even analysts with similar ratings can have vastly different price targets, so always understand the reasoning behind an analyst's view.

How to Use Analyst Ratings

Here are a few pointers on incorporating analyst ratings into your investment research.

Step 1: Don't rely on a single analyst.

Using an array of analysts (buy- and sell-side) gives inventors the most possible information. Don't just look for analysts with similar opinions as yourself — ensure you understand the pros and cons of each investment you make by incorporating positive and negative views, if possible.

Step 2: Compare analyst ratings across the industry or sector.

It's easy to slap a "buy" rating on a stock and predict a winner, but comparing stocks against others in the sector can offer insight into the rating. For example, if a stock is rated "buy" in the information technology sector, but a dozen others are rated "strong buy" by the same analyst, where is your capital best served?

Step 3: Consider your own goals and risk tolerance.

You might find stocks rated "strong buy" in your research in sectors you wish to avoid. That's fine! There are thousands of securities across dozens of industries in the public markets, and you don't need to purchase every share that comes with a "buy" rating. Instead, stick to your investment plan.

Step 4: Don't stubbornly stick to your original assessments.

Following your investment plan and using analyst ratings as guidelines are practical steps, but things can change over time. Today's "strong buy" stocks could be "strong sell" stocks down the road. Using an aggregate of analysts' ratings can help investors view stocks from a higher level. For example, if the number of "buy" ratings on a stock drops 40% over a few years, you might want to take a closer look at that particular company.

Why Are Analyst Ratings Important?

Checking out analyst ratings isn't a necessary step for investing, but it can be helpful for those looking to dig deep into an asset's prospects. Analyst research often has quotes from company executives, questions from conference calls and in-depth reporting on the company's balance sheet, income statement and other essential documents. Analysis like this is complex for individual investors to do on their own, especially considering how frequently analysts interact with the executives they cover. But access often comes with a downside, which we discuss more below.

How Accurate Are Analyst Ratings?

Both buy and sell-side analysts strive for accuracy because giving consistently wrong commendations can be hazardous for job security. However, investors should be aware that analysts might not always have the best interest of the retail investor at heart when making their recommendations.

For starters, being an analyst requires access to company employees and management. Analysts typically ask questions during conference calls and speak with C-suite executives on the record about their firms' prospects. Executives usually don't want to hear adverse reports about their companies, so analysts are incentivized to paint a rosy picture to retain access. The SEC has been questioning the authenticity of analyst ratings (especially on the sell-side) since 2002 when it asked bluntly, "Why are there so few sell ratings?"

Of course, there are other areas of the securities analysis market to face scrutiny. If you recall, during the 2008 financial crisis, the biggest credit rating agencies were all held to the fire due to claims that conflicts of interest influenced their ratings. The biggest rating agencies in the world were accused of "misrepresenting the risks associated with mortgage-backed securities." Remember, analyst ratings aren't spat out by computer algorithms but by living, breathing people who may have agendas other than providing the most precise and accurate reports on a company's future prospects.

Analyst Ratings Can Guide Investors, but Don't Treat Them as Gospel

Consider each type of investment research or advice in collaboration. Even the most accurate and thoughtful analysts get things wrong, plus ratings are frequently besieged with conflicts of interest. But analyst coverage does offer research that's difficult to get elsewhere, and using an array of analyst reports can give investors a deeper understanding of the securities they buy.

FAQs

Still have questions about analyst ratings? Here are a few answers to some common points of discussion:

What are analyst ratings?

Analyst ratings are the "buy" and "sell" labels, plus price targets, that investment researchers attach to specific securities. These ratings are based on financial data, earnings reports and conversations with company executives.

Should you trust analyst ratings?

Analyst ratings provide plenty of helpful information, but you shouldn't use an analyst's "buy" rating as the sole reason you purchase a security. Analysts aren't immune to conflicts of interest or outside parties' influence, so ensure you always understand why a stock was labeled a "buy" or "sell."

What does an analyst rating tell you about a stock?

Ratings give investors the analyst's overall opinion about a particular stock and price targets based on the company's valuation and prospects. Analysts often attend conference calls, ask questions and provide in-depth information about companies that are difficult to acquire elsewhere.

Stock Forecasts and Research Tools

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Price Forecasts for Popular Stocks

Top Stock Recommendations by Brokerage

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Stock Price Targets and Analyst Ratings